(The Economist) – Phage therapy, as this practice is known, fell out of favour in the West after the development of antibiotics, although it continued in parts of the old Soviet sphere of influence. (These days, research is still carried out in Georgia and Poland). But antibiotics are faltering as resistant strains of germ evolve. Some Western researchers are therefore looking afresh at phages, hoping, with modern methods, to turn them into tailored treatments for infection.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.